Global Markets Direct's, 'Breast Cancer - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Breast Cancer, complete with latest updates, and special features on late-stage and discontinued projects. https://www.reportscorner.com/reports/15403/Breast-Cancer---Pipeline-Review,-H1-2013/

1. RC
Reports Corner
Breast Cancer - Pipeline Review, H1 2013

2. DescriptionDescription
Reports Cornerwww.reportscorner.com
Global Markets Direct's, 'Breast Cancer - Pipeline Review, H1
2013', provides an overview of the indication's therapeutic
pipeline. This report provides information on the therapeutic
development for Breast Cancer, complete with latest updates, and
special features on late-stage and discontinued projects.

3. Brief SummaryBrief Summary
Reports Cornerwww.reportscorner.com
Global Markets Direct's, 'Breast Cancer - Pipeline Review, H1
2013', provides an overview of the indication's therapeutic
pipeline. This report provides information on the therapeutic
development for Breast Cancer, complete with latest updates, and
special features on late-stage and discontinued projects. It also
reviews key players involved in the therapeutic development for
Breast Cancer. Breast Cancer - Pipeline Review, Half Year is built
using data and information sourced from Global Markets Direct's
proprietary databases, Company/University websites, SEC filings,
investor presentations and featured press releases from
company/university sites and industry-specific third party
sources, put together by Global Markets Direct's team.
Note*: Certain sections in the report may be removed or altered
based on the availability and relevance of data for the indicated
disease.

4. Brief SummaryBrief Summary
Reports Cornerwww.reportscorner.com
Scope
- A snapshot of the global therapeutic scenario for Breast Cancer.
- A review of the Breast Cancer products under development by
companies and universities/research institutes based on
information derived from company and industry-specific sources.
- Coverage of products based on various stages of development
ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and
combined therapeutics.
- Coverage of the Breast Cancer pipeline on the basis of route of
administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

5. Brief SummaryBrief Summary
Reports Cornerwww.reportscorner.com
Reasons to buy
- Identify and understand important and diverse types of
therapeutics under development for Breast Cancer.
- Identify emerging players with potentially strong product
portfolio and design effective counter-strategies to gain
competitive advantage.
- Plan mergers and acquisitions effectively by identifying players
of the most promising pipeline.
- Devise corrective measures for pipeline projects by
understanding Breast Cancer pipeline depth and focus of
Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by
identifying prospective partners with the most attractive projects
to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued
projects and understanding the factors that drove them from
pipeline.

6. Table of ContentsTable of Contents
Reports Cornerwww.reportscorner.com
Table of Contents
Table of Contents 2
Introduction 12
Breast Cancer Overview 13
Therapeutics Development 14
Breast Cancer Therapeutics under Development by Companies 16
Breast Cancer Therapeutics under Investigation by Universities/Institutes 37
Late Stage Products 44
Mid Clinical Stage Products 45
Early Clinical Stage Products 46
Discovery and Pre-Clinical Stage Products 47
Breast Cancer Therapeutics - Products under Development by Companies 48
Breast Cancer Therapeutics - Products under Investigation by Universities/Institutes 83
Companies Involved in Breast Cancer Therapeutics Development 91
Breast Cancer - Therapeutics Assessment 335

7. Table of ContentsTable of Contents
Reports Cornerwww.reportscorner.com
Drug Profiles 343
Breast Cancer Therapeutics - Drug Profile Updates 423
Breast Cancer Therapeutics - Discontinued Products 469
Breast Cancer Therapeutics - Dormant Products 477
Breast Cancer - Product Development Milestones 505
Appendix 513

8. For more informationFor more information
Reports Cornerwww.reportscorner.com
For more information please visit our website
https://www.reportscorner.com/reports/15403/Breast-Cancer---Pipeline-Review,-H1-
2013/

9. Reports Corner
Thank YouThank You
www.reportscorner.com
RC
Contact us: contact@reportscorner.com

10. Reports Corner
Thank YouThank You
www.reportscorner.com
RC
Contact us: contact@reportscorner.com